Core Viewpoint - A securities class action lawsuit has been filed against TransMedics Group, Inc. for alleged misconduct during the Class Period from February 28, 2023, to January 10, 2025, with a lead plaintiff deadline set for April 15, 2025 [1]. Allegations Against TransMedics - The complaint alleges that TransMedics engaged in unethical practices, including the use of kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue [3]. - It is claimed that TransMedics engaged in unsafe practices, concealed safety issues, and lacked proper safety oversight, which increased the company's regulatory risk [3]. Lead Plaintiff Process - Investors in TransMedics can seek to be appointed as a lead plaintiff representative by April 15, 2025, or may choose to remain absent from the class [4]. - The lead plaintiff will represent the interests of all class members and select counsel to direct the litigation [4].
TMDX Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against TransMedics Group, Inc. (TMDX)